This Article Full Text Full Text (PDF) Correction (v100,p2205) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Kodolitsch, Y. Articles by Rogan, P. K. Search for Related Content PubMed PubMed Citation Articles by von Kodolitsch, Y. Articles by Rogan, P. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-METHIONINE Medline Plus Health Information Genes and Gene Therapy Related Collections Lipids Pathophysiology Risk Factors Genetics of cardiovascular disease

(Circulation. 1999;100:693-699.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Splice-Site Mutations in Atherosclerosis Candidate Genes

Relating Individual Information to Phenotype

Yskert von Kodolitsch, MD; Reed E. Pyeritz, MD, PhD; Peter K. Rogan, PhD

From the Department of Cardiology (Y.v.K.), University Hospital Eppendorf, Hamburg, Germany; Departments of Human Genetics, Medicine, and Pediatrics (R.E.P.), Allegheny General Hospital, Pittsburgh, Pa; and Section of Molecular Genetics and Molecular Medicine (P.K.R.), Children's Mercy Hospital, Kansas City, Mo.

Correspondence to Peter K. Rogan, PhD, Section of Molecular Genetics and Molecular Medicine, Children's Mercy Hospital and Clinics, 2401 Gillham Road, Kansas City, MO 64108. E-mail progan{at}cmh.edu

Background—Nucleotide variants in several genes for lipid and methionine metabolism influence the risk of premature atherosclerosis. Ten percent of single nucleotide substitutions in these genes involve mRNA splice sites. The effects of some of these changes on splicing and on phenotypic severity are not inherently obvious.

Methods and Results—Using an information theory-based model, we measured the individual information content (R_i, in bits) of splice sites adjacent to 289 mutations (including 31 splice-site mutations) in the atherosclerosis candidate genes APOAII, APOB, APOCII, APOE, CBS, CETP, LCAT, LIPA, LDLR, and LPL. The predictions of information analysis were then corroborated by published mRNA analyses. The R_i values of mutant sites were consistent with either complete (n=17) or partial (n=8) inactivation of these sites. Seven mutations were predicted to activate cryptic splice sites. Predicted inactive mutant sites were associated with either "average" or "severe" dyslipidemia and commensurate reductions in protein levels or activity, whereas mutations expected to exhibit residual splicing had average or "mild" effects on lipid and protein expression.

Conclusions—Information analysis of splice-junction variants in atherosclerosis candidate genes distinguishes inactive from leaky splice sites and identifies activated cryptic sites. Predicted changes in splicing were related to phenotypic severity.

Key Words: atherosclerosis • genetics • lipids • risk factors • RNA

This article has been cited by other articles:

				H. Lei, I. N. M. Day, and I. Vorechovsky Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer Nucleic Acids Res., July 14, 2005; 33(12): 3897 - 3906. [Abstract] [Full Text] [PDF]

				C. A. Vyhlidal, P. K. Rogan, and J. S. Leeder Development and Refinement of Pregnane X Receptor (PXR) DNA Binding Site Model Using Information Theory: INSIGHTS INTO PXR-MEDIATED GENE REGULATION J. Biol. Chem., November 5, 2004; 279(45): 46779 - 46786. [Abstract] [Full Text] [PDF]

				T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF]

				T. M. Doherty, L. A. Fitzpatrick, A. Shaheen, T. B. Rajavashisth, and R. C. Detrano Genetic Determinants of Arterial Calcification Associated With Atherosclerosis Mayo Clin. Proc., February 1, 2004; 79(2): 197 - 210. [Abstract] [PDF]

				T. E. Thompson, P. K. Rogan, J. I. Risinger, and J. A. Taylor Splice Variants but not Mutations of DNA Polymerase {beta} Are Common in Bladder Cancer Cancer Res., June 1, 2002; 62(11): 3251 - 3256. [Abstract] [Full Text] [PDF]

				M. Li and P. H. Pritchard Characterization of the Effects of Mutations in the Putative Branchpoint Sequence of Intron 4 on the Splicing within the Human Lecithin:cholesterol Acyltransferase Gene J. Biol. Chem., June 9, 2000; 275(24): 18079 - 18084. [Abstract] [Full Text] [PDF]

				E. J. Topol, J. McCarthy, S. Gabriel, D. J. Moliterno, W. J. Rogers, L. K. Newby, M. Freedman, J. Metivier, R. Cannata, C. J. O'Donnell, et al. Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction Circulation, November 27, 2001; 104(22): 2641 - 2644. [Abstract] [Full Text] [PDF]